Literature DB >> 2816220

Serum and tissue pharmacokinetics of intravenous metronidazole in surgical patients.

P A Kling1, L G Burman.   

Abstract

Intravenous administration of 1 g metronidazole during 30 min to 12 patients undergoing colorectal surgery yielded mean serum levels of 20.4 (+/- 4.9 SD) mg/l at 1 h, 15.6 (+/- 4.1) at 4 h and 3.9 (+/- 2.0) at 24 h after infusion. The mean elimination half-life of metronidazole was 8 h and the mean apparent volume of distribution 42 l. At 1-4 h after the infusion the median tissue/serum drug concentration ratio was 0.94 for rectus abdominis muscle and 0.76 for colonic mucosa. For adipose tissue the corresponding ratio was significantly lower (0.21, p less than 0.01) and highly unpredictable. Since in gastrointestinal surgery most wound infections develop in the cut surface of the abdominal fat, failure of metronidazole to reach bactericidal concentrations in adipose tissue could be a risk factor in this respect, contributing to the variable reported results of metronidazole prophylaxis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2816220

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  4 in total

1.  Perioperative penetration of metronidazole into muscle tissue: a microdialysis study.

Authors:  Juri Karjagin; Rein Pähkla; Joel Starkopf
Journal:  Eur J Clin Pharmacol       Date:  2003-10-29       Impact factor: 2.953

2.  Prospective observational study comparing three different treatment regimes in patients with Clostridium difficile infection.

Authors:  Judith M Wenisch; Daniela Schmid; Hung-Wei Kuo; Franz Allerberger; Verena Michl; Philip Tesik; Gerhard Tucek; Hermann Laferl; Christoph Wenisch
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

Review 3.  Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.

Authors:  K C Lamp; C D Freeman; N E Klutman; M K Lacy
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

Review 4.  Metronidazole. A therapeutic review and update.

Authors:  C D Freeman; N E Klutman; K C Lamp
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.